PDE# inhibitors

Related by string. * : PDE# / Inhibitor . Inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . proton pump inhibitor PPI . ACE inhibitors . inhibitors . Proton Pump Inhibitors PPIs . selective serotonin reuptake inhibitors . angiotensin converting enzyme inhibitors . HMG CoA reductase inhibitors . HMG CoA reductase inhibitor * *

Related by context. Frequent words. (Click for all words.) 72 nicotinic alpha 7 70 Factor VIIa 68 Lu AA# 67 deforolimus 67 TACI Ig 67 myeloproliferative disorders 67 Guanilib 66 Shigamabs ® 66 Mipomersen 66 Fibrillex TM 66 bicifadine 66 phase IIa clinical 66 PEG SN# 66 GLPG# 66 Nanobody 66 EndoTAG TM -1 66 therapeutic monoclonal antibodies 66 Solzira 66 Panzem R 65 elotuzumab 65 GRNVAC1 65 PSN# [002] 65 dacetuzumab 65 INCB# [001] 65 Aurexis 65 immunological diseases 65 IMC #B 65 DDP# 65 ponatinib 65 otelixizumab 65 Milnacipran 65 outlicensing 65 WILEX 65 CGEN # 65 ATL# [001] 65 vosaroxin 65 Daclizumab 65 Azedra 65 MEK inhibitor 65 desvenlafaxine 64 enzastaurin 64 faropenem 64 Desmoteplase 64 AEG# 64 Bicifadine 64 pradefovir 64 INTEGRILIN 64 CCX# 64 molecular biomarkers 64 proteasome inhibitor 64 atacicept 64 RGB # 64 ASONEP 64 methylnaltrexone 64 Shigamabs R 64 Phase Ib II 64 predictive biomarkers 64 immuno inflammatory diseases 64 Vilazodone 64 Prestara 63 Rebif ® 63 R sorafenib tablets 63 Nanobodies 63 Cethrin 63 FLT3 63 forodesine 63 JAK3 63 neuroprotective properties 63 Phase IIb trials 63 Cetrorelix 63 Nuvion 63 Oncaspar 63 HCV protease inhibitor 63 Chemokine 63 targeting CD# 63 novel antibody therapeutics 63 BNC# 63 therapeutically relevant 63 Microplasmin 63 multiple myeloma MM 63 SERMs 63 KRN# 63 Entereg R 63 Retigabine 63 GSK # 63 TLR9 agonist 63 diagnostic biomarkers 63 Proxinium TM 63 GSK# [001] 63 BZL# 63 Sym# 63 Amplimexon 63 epothilone 63 cardiovascular metabolic 63 phase IIb clinical 62 liposomal formulation 62 pertuzumab 62 multi kinase inhibitor 62 Elafin 62 nonclinical studies 62 Clonicel

Back to home page